MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Deep brain stimulation (DBS)"

  • 2017 International Congress

    Neuropsychological predictors of patient-reported cognitive outcomes following deep brain stimulation

    K. Mills, K. Donohue, A. Swaminathan, J.-M. Leoutsakos, J. Brandt (Baltimore, MD, USA)

    Objective: To identify preoperative cognitive performance measures associated with patient- and/or caregiver-reported cognitive decline following deep brain stimulation (DBS) surgery for movement disorders. Background: Patients…
  • 2017 International Congress

    Dynamics of subthalamic nucleus beta bursts in Parkinson’s disease during ON and OFF dopaminergic state

    G. Tinkhauser, A. Pogosyan, H. Tan, A. Kühn, P. Brown (Oxford, United Kingdom)

    Objective: To investigate the dynamics of beta bursts in subthalamic nucleus (STN) local field potentials (LFP) in patients with Parkinson’s disease (PD) before and after…
  • 2017 International Congress

    The non-motor symptoms in Parkinsons’s disease patients treated with STN DBS: the follow up study

    M. Mencinger, M. Červek, T. Rus, G. Jakob, D. Georgiev, D. Flisar, R. Rajnar, M. Benedičič, K. Boetzel, J. Mehrkens, Z. Pirtošek, M. Trošt (Ljubljana, Slovenia)

    Objective: The aim of the study was to follow-up the effect of STN DBS on motor and non-motor symptoms in aPD.  Background: A comprehensive assessment…
  • 2017 International Congress

    Pathological crying induced by deep brain stimulation of the subthalamic nucleus in Parkinsons’ disease

    M. Wolf, M. Abdallat, C. Blahak, J. Krauss (Mannheim, Germany)

    Objective: To report on a patient with Parkinsons’ disease (PD) who developed pathologic crying (PC) following chronic deep brain stimulation (DBS) of the subthalamic nucleus…
  • 2017 International Congress

    Effects of thalamic deep brain stimulation on posture and balance in patients with essential tremor

    K. Lizarraga, A. Farooqi, A. Rasul, J. Jagid, C. Luca (Miami, FL, USA)

    Objective: To characterize posture and balance dysfunction in patients with essential tremor (ET) after undergoing deep brain stimulation (DBS) of the thalamic nucleus ventralis intermedius…
  • 2017 International Congress

    Experience Of Pallidal Deep Brain Stimulation (DBS) In Dystonia At A Tertiary Care Centre In India.

    D. Srinivas, P. Pal, R. Yadav (Bangalore, India)

    Objective: Dystonia is one of the most debilitating movement disorders. Pallidal DBS has been revolutionary for the management of medically refractory dystonia.  Although DBS of…
  • 2017 International Congress

    Deep brain stimulation in Parkinson’s disease: Outcome after more than nine years

    B. Thomsen, S. Jensen, A. Clausen, B. Jespersen, M. Karlsborg, A. Løkkegaard (Copenhagen, Denmark)

    Objective: The aim of this study is to examine the long-term effects of deep brain stimulation of the subthalamic nucleus (STN DBS) in Parkinson’s disease…
  • 2017 International Congress

    Safety of Unilateral and Bilateral DBS implants in ET: Preliminary results from Product Surveillance Registry

    M. Schiess, S. Falowski, G. Plotkin, S. Palfi, T. Witt, E. Cuny, T. Theys, K. Martinez, R. Plunkett, Y. Temel, G. Johnson, T. Weaver, J. Krauss, P. Konrad (Houston, TX, USA)

    Objective: To compare the safety of unilateral  (Uni) to bilateral (Blt) DBS implants in Essential Tremor (ET).  Background: DBS is an effective therapy in reducing…
  • 2017 International Congress

    Safety and tolerability of deep brain stimulation in early stage Parkinson’s disease: Five-year follow-up of medication use and adverse events

    A. Currie, M. Turchan, L. Heusinkveld, S. Millan, M. Hacker, A. Molinari, C. Gill, T. Davis, P. Konrad, F. Phibbs, P. Hedera, D. Charles (Memphis, TN, USA)

    Objective: To evaluate the long-term safety and tolerability of subthalamic nucleus deep brain stimulation (DBS) for early stage Parkinson’s disease (PD). Background: Twenty-nine subjects with…
  • 2017 International Congress

    Cognitive safety of eight-hours adaptive deep brain stimulation (aDBS) in Parkinson’s disease

    R. Ferrucci, F. Ruggiero, F. Cortese, T. Bocci, M. Rosa, M. Arlotti, M. Colombo, S. Marceglia, F. Mameli, F. Cogiamanian, G. Ardolino, M. Locatelli, P. Rampini, A. Priori (Milan, Italy)

    Objective: The purpose of this study is to assess the effects of eight-hours aDBS on neuropsychological functions in patients with Parkinson's disease (PD). Background: Adaptive…
  • « Previous Page
  • 1
  • …
  • 141
  • 142
  • 143
  • 144
  • 145
  • …
  • 169
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley